Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
1.
Indian J Med Sci ; 2010 Mar; 64(3) 99-103
Article de Anglais | IMSEAR | ID: sea-145493

RÉSUMÉ

Background and Objectives: Tuberculosis (TB) remains one of the major causes of death from a single infectious agent worldwide. Its resurgence in 1990s is primarily due to co-infection with HIV and the emergence of multi-drug-resistant (MDR) strains. Our objectives in this study were demonstration and grading of acid-fast bacilli in smears from sputum specimens of clinically newly diagnosed pulmonary TB patients, isolation of the organism, speciation and drug susceptibility testing of Mycobacterium tuberculosis isolates to isoniazid (H), rifampicin (R), streptomycin (S), and ethambutol (E). Materials and Methods: Sputum specimens were collected from 150 patients. Smear examination was done after Ziehl-Neelsen staining. The specimens were cultured onto Lowenstein Jensen media after Petroff's method of concentration. The growth was identified as M. tuberculosis with standard tests. Sensitivity of 50 isolates of tubercle bacilli to anti-TB drugs H, R, S, E were determined by Resistance-Ratio method. Results: Out of 150 sputum specimens examined, 62(41.3%) were smear positive. Out of these 62,56 grew on culture. 50 isolates of M. tuberculosis were picked up for drug susceptibility testing. Total of 31 (62%) were resistant to S, 14(28%) to H, 9(18%) to R, 6(12%) were resistant to E and 2 strains (4%) were resistant to H and R. Conclusion: From the small cohort, incidence of primary MDR-TB was found to be 4% in this region, which is within the expected range.


Sujet(s)
Études de cohortes , Multirésistance bactérienne aux médicaments , Humains , Inde/épidémiologie , Isoniazide/usage thérapeutique , Tests de sensibilité microbienne/méthodes , Mycobacterium tuberculosis/effets des médicaments et des substances chimiques , Mycobacterium tuberculosis/isolement et purification , Rifampicine/usage thérapeutique , Tuberculose multirésistante/traitement médicamenteux , Tuberculose multirésistante/épidémiologie
2.
Article de Anglais | IMSEAR | ID: sea-113021

RÉSUMÉ

Bottled water is generally accepted as safe for consumption. However, its potability is uncertain. Ninety samples of Six national and 3 local brands marketed in Mangalore City were studied. Seven of these were ISI certified. Bacteriological analysis of these samples were carried out for viable count, presumtive coliform count by multiple tube method, confirmed Esch. coli count by Eijkman test and specific intestinal pathogens, such as Salmonella, Shigella and Vibrios. Thirty out of 90 samples though free from coliforms, had viable count much higher than specified by Bureau of Indian Standard. Three samples of one of the brands which is ISI not certified had Esch. coli with most probable number 18/100 ml and Salmonella typhimurium. It is concluded that bottled water can not be taken for granted to be safe.


Sujet(s)
Bactéries/isolement et purification , Numération de colonies microbiennes , Sécurité des produits de consommation , Humains , Inde , Eau/normes , Microbiologie de l'eau
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE